Understanding the Differences Between SCID, Autoimmune Diseases, and GVHD

Immune system disorders can arise from too little immunity, too much immunity, or the immune system attacking the body itself. SCID, autoimmune diseases such as SLE and rheumatoid arthritis (RA), and graft-versus-host disease (GVHD) each represent a different pattern of immune dysfunction.

SCID – Immunodeficiency (Too Little Immunity)

Severe Combined Immunodeficiency (SCID) is a genetic disorder where T cells and B cells fail to develop properly. This leaves patients with extremely weak immunity.

Key points:

• Caused by genetic mutations (IL2RG, ADA, RAG1/2, JAK3)
• Infants have recurrent infections, pneumonia, chronic diarrhea
• Requires urgent treatment (bone marrow transplant or gene therapy)
• Without treatment, the disease can be fatal early in life

SCID = immune system cannot defend the body

Autoimmune Diseases – Overactive Immunity (Attacking Self)

Autoimmune diseases are the opposite of SCID—the immune system becomes too active and mistakenly attacks healthy tissues.

Common examples:

Systemic Lupus Erythematosus (SLE)

• Immune system attacks skin, joints, kidneys, brain
• Inflammation is widespread
• Autoantibodies such as ANA and anti-dsDNA damage organs
• Flares and remissions occur frequently

Rheumatoid Arthritis (RA)

• Immune system attacks joints
• Causes chronic inflammation, swelling, cartilage destruction, deformity
• Driven by cytokines such as TNF-α and IL-6

Autoimmunity = immune system becomes destructive and mis-targeted.

GVHD – Immune Attack From Donor Cells

Graft-versus-host disease (GVHD) occurs after stem cell or bone marrow transplantation.

What happens?

• Donor immune cells see the patient’s tissues as “foreign”
• They attack the host’s skin, gut, liver, and other organs
• Can be acute or chronic
• Major cause of transplant-related complications

GVHD = donor immune cells attack the patient’s body

Why These Conditions Occur — Biological Mechanisms

Though these diseases seem very different, they share underlying biological patterns involving T cells, cytokines, and immune regulation.

Why SCID Happens

SCID is caused by genetic mutations that prevent immune cells from developing.

Examples:

• IL2RG mutation → X-linked SCID (most common)
• ADA deficiency → toxic metabolites kill lymphocytes
• RAG1/2 mutations → failure to produce T-cell and B-cell receptors

Result:

• Immune system is “empty”
• Patients are defenseless against infections

Why Autoimmune Disease Happens (SLE, RA)

Autoimmunity is caused by immune system misrecognition.

Mechanisms include:

• Loss of immune tolerance
• Overactivation of B cells producing autoantibodies
• Chronic elevation of inflammatory cytokines
• Mitochondrial dysfunction
• Environmental triggers (UV, infections, hormones, smoking)

SLE: immune complexes damage kidneys, skin, brain
RA: immune attack destroys cartilage and joints

The immune system is overactive but misguided.

Why GVHD Happens

GVHD results from immune incompatibility after transplantation.

Mechanism:

• Donor T cells attack host tissues
• Cytokine storms damage organs
• Chronic GVHD results in fibrosis, dry eyes, skin tightening, and organ dysfunction

GVHD = inflammatory overreaction triggered by donated immune cells.

How UC-MSC Stem Cell Therapy Helps: Immune Modulation & Tissue Repair

Mesenchymal stem cells (MSCs), especially UC-MSCs sourced from TISTR GMP-certified labs, offer powerful immune-regulating and anti-inflammatory effects supported by global research.

MSC therapy is not a cure for these diseases — but plays a significant adjunctive role in improving immune balance and reducing inflammation.

Why UC-MSCs are effective for immune disorders

UC-MSCs have unique immune-regulating capacities:

• Reduce inflammatory cytokines: TNF-α, IL-6, IL-1β
• Increase anti-inflammatory cytokines: IL-10, TGF-β
• Suppress overactive T cells and B cells
• Promote regulatory T cells (Tregs) that calm autoimmunity
• Reduce oxidative stress
• Repair organ and tissue damage through paracrine signals
• Improve mitochondrial function in damaged cells

Research strongly supports MSCs for immune modulation

How Stem Cells Help in SCID (Supportive Role)

MSC therapy does NOT replace bone marrow transplantation or gene therapy.
But UC-MSCs provide supportive benefits:

• Reduce inflammatory complications after infection
• Encourage tissue recovery in gut, lungs, or liver
• Improve bone-marrow engraftment after HSCT
• Reduce severity of GVHD if it occurs
• Promote immune system rebalancing

Several clinical studies show MSCs help reduce transplant-related inflammation and assist immune recovery

How Stem Cells Help in Autoimmune Diseases (SLE / RA)

MSC therapy is more extensively studied in autoimmune diseases than in SCID.

In SLE, UC-MSCs may:

• Reduce autoantibody production
• Protect kidneys from inflammation
• Improve fatigue and pain
• Reduce flares
• Improve immune tolerance (Treg increase)

In RA, UC-MSCs may:

• Reduce joint inflammation
• Protect cartilage from immune destruction
• Lower inflammatory markers (CRP, ESR)
• Improve mobility and reduce pain

Meta-analyses show MSC therapy significantly improves autoimmune disease symptoms and reduces inflammatory cytokines

How Stem Cells Help in GVHD

MSC therapy is one of the most proven applications for GVHD.

Global studies confirm MSCs help:

• Suppress T-cell overactivation
• Reduce cytokine storms
• Improve symptoms such as skin rash, diarrhea, liver inflammation
• Reduce relapse risk after HSCT

MSC therapy is FDA-recognized as a treatment for steroid-resistant GVHD in the United States (remestemcel-L). This is one of the strongest scientific indications for MSC use.

Why EDNA Wellness Uses Only TISTR GMP–Certified UC-MSCs

TISTR certification assures:

• GMP-grade manufacturing
• Verified identity, purity, viability
• Complete sterility testing
• Clear COA for every batch
• Consistent biological potency
• Compliance with Thai medical regulations

This ensures patient safety and treatment reliability for immune-related conditions.

SCID, autoimmune diseases like SLE/RA, and GVHD represent three different types of immune dysfunction, yet all involve abnormal immune signaling and inflammation.

UC-MSC therapy offers significant immune-modulating and tissue-repair benefits that complement standard medical treatments. While not a cure, MSCs can help reduce inflammation, repair damaged tissues, and regulate immune balance.

About EDNA Wellness

EDNA Wellness is a private clinic specializing in Stem Cell Therapy in Bangkok, Thailand for Neurology & Stroke as well as Bones & Joints. Beyond rehabilitation, we also provide aesthetic and wellness treatments to support your full-body vitality. All delivered with expert care and compassion

For more information or inquiries, contact us via

LINE @ednawellness

WhatsApp +66 (0) 64 505 5599

www.ednawellness.com

References

• Le Blanc, K., et al. (2012). Mesenchymal stromal cells for treatment of graft-versus-host disease. The Lancet, 371, 1579–1586.
• Mamcarz, E., et al. (2019). Gene therapy for ADA-SCID: Long-term outcomes. New England Journal of Medicine, 380, 451–463.
• Squillaro, T., Peluso, G., & Galderisi, U. (2016). Clinical trials with mesenchymal stem cells: An update. Cell Transplantation, 25, 829–848.
• Wang, D., Zhang, H., & Liang, J. (2020). MSC therapy for autoimmune diseases: A systematic review. Stem Cell Research & Therapy, 11, 314.
• Kwan, A., et al. (2014). Newborn screening for SCID. Journal of Allergy and Clinical Immunology, 133, 597–603.
• Burt, R. K., et al. (2020). Stem cell therapy for immune disorders. Nature Reviews Rheumatology, 16, 1–15.